Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Addressing Physician Dispensed Medications with Price Opportunist Drug Strategies
Does your pharmacy program have strategies in place to manage physician dispensed medications, such as dermatologicals and other high-cost products
Workers' Comp
Article
What Do We Know About Post-COVID Conditions?
Initial diagnosis and recovery doesn’t mean the end of dreaded virus Post-COVID conditions is the CD
Workers' Comp
White Paper
Food For Thought - Provider Engagement, Access, Quality and Compliance
Quality medical care starts with quality ingredients • Accurate provider information • Strong provider relationships
Workers' Comp
Article
The rising retirement rate is changing the U.S. workforce
The average number of baby boomers who retire from the U.S.
Workers' Comp
News Release
Workers compensation.com: WC Experts Opine on Latest Guidance on ADA and COVID-19 Long Haulers
People suffering with lingering symptoms after having COVID-19 may be covered under the Americans with Disabilities Act.
Watch On-Demand
CE Webinar
Post-Covid Conundrum
On-Demand
Presented by: Tammy Bradly, VP Clinical Product Development